Physician profile
Devon Price
NPI 1336731124
$4,668.07
in general payments reported to CMS, 2019-2025
36 companies · $701 in 2025
The $701 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $400 · 2022: $843 · 2023: $1,529 · 2024: $1,195 · 2025: $701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,424.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $570.23 | 2021-2025 | |
| Novo Nordisk INC | $523.23 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $429.93 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $361.18 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $311.11 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $301.12 | 2021-2023 | Jardiance |
| Glaxosmithkline, LLC. | $271.60 | 2022-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $178.16 | 2022-2024 | |
| Abbott Laboratories | $162.13 | 2023 | Freestyle Libre 2 |
| Amgen INC. | $156.20 | 2022-2025 | Repatha, Otezla, Evenity |
| Exact Sciences Corporation | $124.09 | 2023-2024 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $122.04 | 2023-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $117.49 | 2024-2025 | Caplyta |
| Nevro Corp. | $115.92 | 2023-2024 | Senza |
| Dexcom, INC. | $112.89 | 2021-2025 | Dexcom G6 Transmitter |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.